JRP
SAGE

Jasper Ridge Partners’s Sage Therapeutics SAGE Stock Holding History

Jasper Ridge Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-35,152
Closed -$2.57M – 87
2015
Q2 		$2.57M Buy
+35,152
New +$2.26M 0.18% 36

Other funds holding SAGE

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Jasper Ridge Partners's SAGE Position: Q3 2015 in Review

Jasper Ridge Partners sold out of Sage Therapeutics (SAGE) in Q3 2015, closing a stake of 35,152 shares — an estimated $2.57M sold.

Jasper Ridge Partners first reported a position in SAGE in Q2 2015 and held it in 1 quarter. The position peaked at $2.57M in Q2 2015. 135 funds tracked by Wall St. Rank hold SAGE as of Q3 2015.

  • Jasper Ridge Partners reported no remaining Sage Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Jasper Ridge Partners sold 35,152 Sage Therapeutics shares in Q3 2015, an estimated $2.57M.
  • Jasper Ridge Partners first reported a position in Sage Therapeutics in Q2 2015 and held it in 1 quarter.
  • Jasper Ridge Partners's Sage Therapeutics position peaked at $2.57M in Q2 2015.
  • 135 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2015.

Based on Jasper Ridge Partners's 13F filing for Q3 2015, filed 10 Nov 2015.